Saved by a SNP

At a time when venture dollars for cardiovascular companies are dwindling, DalCor Pharma U.K. Ltd. found a syndicate willing to go against the grain.

Heart disease is still a leading cause of mortality, but many VCs have treated the space as a no-fly zone. For the past six years, investments in private cardiovascular companies have been a shrinking piece of the venture pie. ...